EP1283897A4 - Gene responsible for stargardt-like dominant macular dystrophy - Google Patents

Gene responsible for stargardt-like dominant macular dystrophy

Info

Publication number
EP1283897A4
EP1283897A4 EP01935445A EP01935445A EP1283897A4 EP 1283897 A4 EP1283897 A4 EP 1283897A4 EP 01935445 A EP01935445 A EP 01935445A EP 01935445 A EP01935445 A EP 01935445A EP 1283897 A4 EP1283897 A4 EP 1283897A4
Authority
EP
European Patent Office
Prior art keywords
stargardt
macular dystrophy
gene responsible
dominant macular
dominant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01935445A
Other languages
German (de)
French (fr)
Other versions
EP1283897A2 (en
Inventor
Konstantin Petrukhin
Wen Li
Kang Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Johns Hopkins University
Original Assignee
Merck and Co Inc
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc, Johns Hopkins University filed Critical Merck and Co Inc
Publication of EP1283897A2 publication Critical patent/EP1283897A2/en
Publication of EP1283897A4 publication Critical patent/EP1283897A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP01935445A 2000-05-16 2001-05-11 Gene responsible for stargardt-like dominant macular dystrophy Withdrawn EP1283897A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20499000P 2000-05-16 2000-05-16
US204990P 2000-05-16
PCT/US2001/015464 WO2001087921A2 (en) 2000-05-16 2001-05-11 Gene responsible for stargardt-like dominant macular dystrophy

Publications (2)

Publication Number Publication Date
EP1283897A2 EP1283897A2 (en) 2003-02-19
EP1283897A4 true EP1283897A4 (en) 2004-08-04

Family

ID=22760322

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01935445A Withdrawn EP1283897A4 (en) 2000-05-16 2001-05-11 Gene responsible for stargardt-like dominant macular dystrophy

Country Status (3)

Country Link
EP (1) EP1283897A4 (en)
CA (1) CA2409705A1 (en)
WO (1) WO2001087921A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1341920A2 (en) * 2000-11-29 2003-09-10 Xenon Genetics, Inc. Human elongase genes and uses thereof
CN102177438A (en) 2008-07-25 2011-09-07 理查德·W·瓦格纳 Protein screeing methods
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
EP3495357B1 (en) 2013-03-14 2021-05-05 The Trustees of Columbia University in the City of New York 4-phenylpiperidines, their preparation and use
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
EP2968303B1 (en) 2013-03-14 2018-07-04 The Trustees of Columbia University in the City of New York Octahydrocyclopentapyrroles, their preparation and use
CA2947174C (en) 2014-04-30 2023-02-28 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparaiton and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000070945A2 (en) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Fatty acid elongation genes and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 7 March 2000 (2000-03-07), SIMS S, XP002283261, retrieved from EMBL Database accession no. AL159162 *
EDWARDS A O ET AL: "Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14.", AMERICAN JOURNAL OF OPHTHALMOLOGY. UNITED STATES APR 1999, vol. 127, no. 4, April 1999 (1999-04-01), pages 426 - 435, XP002283260, ISSN: 0002-9394 *

Also Published As

Publication number Publication date
CA2409705A1 (en) 2001-11-22
WO2001087921A3 (en) 2002-03-14
WO2001087921A2 (en) 2001-11-22
EP1283897A2 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
EP1282477B8 (en) Refractory articles
HUP0102268A3 (en) Case for articles
AU2002230769A1 (en) Device for hanging articles
PL369076A1 (en) Piperazine derivative
AU2001287199A1 (en) Vertical conveyor
AU2002352953A1 (en) Support garment for quadrupeds
AU2001268479A1 (en) Part forming machine integrated controller
TW487144U (en) Structure improvement for blowing machine
AU2002356180A1 (en) Methods for inhibiting angiogenesis
EP1283897A4 (en) Gene responsible for stargardt-like dominant macular dystrophy
IL154458A0 (en) Processes for preparing cilostazol
AU2001271869A1 (en) Conveyor bracket
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
AU2001293035A1 (en) Hydrocracking process
AU2001220281A1 (en) Rollerboard for road-skiing
AU6424701A (en) Gasc1 gene
AU2001244358A1 (en) Schizophrenia related genes
AU2001264247A1 (en) GASC1 gene
GB2371332B (en) Independent suspension
HK1033530A2 (en) Suspension bracket for suspension fan
HK1050316A1 (en) Cholesterol lowering agent
EP1165825A4 (en) Toxicant-induced differential gene expression
TW595555U (en) Suspension
AU2132802A (en) Controller
AU2002365852A1 (en) Processes for preparing %a-d-ribofuranose derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021216

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/68 B

Ipc: 7C 12P 21/06 A

Ipc: 7C 07K 14/47 B

Ipc: 7G 01N 33/53 B

Ipc: 7A 61P 27/00 B

Ipc: 7C 12N 1/20 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040622

17Q First examination report despatched

Effective date: 20090204

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090815